AusPAR: Sevelamer hydrochloride

Australian Public Assessment Report

AusPAR

AusPAR: Sevelamer hydrochloride [PDF, 557.72 KB]

AusPAR: Sevelamer hydrochloride [Word, 500.1 KB]

Attachment: Extract from Clinical Evaluation Report: Sevelamer hydrochloride [PDF, 1.14 MB]

Attachment: Extract from Clinical Evaluation Report: Sevelamer hydrochloride [Word, 740.43 KB]

Device/Product Name

Sevelamer GPPL / Sevelamer GxP / Seveligand / Phosligand / APO-Sevelamer / APOTEX-Sevelamer / Chemmart Sevelamer / GenRx Sevelamer / Terry White Chemists Sevelamer

Active ingredients

Sevelamer hydrochloride

AusPAR Date

31 July 2017

Published

14 August 2017

Submission Number

PM-2013-00742-1-3

Submission Type

New generic

Decision

Rejected

Sub menu

AusPAR: Sevelamer hydrochloride

Help us improve the Therapeutic Goods Administration site